| abstract |
α,β-Unsaturated sulfones, sulfoxides and sulfonamides according to Formula I: n n n n n n n n n n wherein Ar 1 , Ar 2 , X, n, * and R are as defined herein are useful for the treatment of proliferative disorders which are resistant to treatment by ATP-competitive kinase inhibitors. |